InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

NovoCure Ltd

NVCR Clue Score34
Fiscal year ends December CIK 0001645113 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
W Anthony Vernon
28 Apr 2026
Director
Exercised, kept
21,500
$11.39
$244.89K
Wilhelmus Cm Groenhuysen
5 Jun 2024
Chief Operating Officer
Exercised, kept indirect
124,373
$22.82
$2.84M
Ashley Cordova
2 Nov 2023
Chief Financial Officer
Exercised, kept
175
$11.46
$2.01K
Ashley Cordova
31 Oct 2023
Chief Financial Officer
Exercised, kept
7,752
$7.15
$55.43K
Ashley Cordova
31 Oct 2023
Chief Financial Officer
Exercised, kept
2,480
$11.44
$28.37K
Ashley Cordova
31 Oct 2023
Chief Financial Officer
Exercised, kept
7,561
$11.46
$86.65K
Ashley Cordova
2 Dec 2022
Chief Financial Officer
Exercised, kept
2,000
$7.15
$14.30K
Ashley Cordova
3 Mar 2022
Chief Financial Officer
Exercised, kept
1,200
$11.46
$13.75K
Ashley Cordova
3 Mar 2022
Chief Financial Officer
Exercised, kept
3,840
$15.60
$59.90K
Pritesh Shah
31 Jul 2021
Chief Commercial Officer
Exercised, kept
3,717
$154.01
$572.46K
Pritesh Shah
3 May 2021
Chief Commercial Officer
Exercised, kept
2,333
$204.10
$476.17K
Showing 250 of 970 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 688
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 414
Sales at will 468
Transactions with no price 2
Shares from compensation/vesting 43,129,995
Sales filed before the plan box existed 394
History held since 5 Oct 2015